Antithyreoidale und TSH-suppressive Behandlung bei Morbus Basedow?
暂无分享,去创建一个
[1] R. Hoermann,et al. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor. , 1997, The Journal of clinical endocrinology and metabolism.
[2] R. Ziegler,et al. Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume. , 1997, European journal of endocrinology.
[3] P. Rae,et al. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. , 1996, The New England journal of medicine.
[4] Sing-yung Wu,et al. Effect of thyroxine administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during antithyroid drug therapy. , 1994, European journal of endocrinology.
[5] P. Carayon,et al. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. , 1994, The Journal of clinical endocrinology and metabolism.
[6] W. Alexander,et al. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. , 1993, The Journal of clinical endocrinology and metabolism.
[7] D. Glinoer,et al. Differences and similarities in the treatment of diffuse goiter in Europe and the United States. , 2009, Experimental and clinical endocrinology.
[8] S. Krabbe,et al. Effect of therapy duration and low and highly dosed thiamazole treatment in Basedow's-Graves' disease. , 2009, Experimental and clinical endocrinology.
[9] K. Ichikawa,et al. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. , 1991, The New England journal of medicine.
[10] R. Fauchet,et al. Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. , 1990, The Journal of clinical endocrinology and metabolism.
[11] P. D. Bewsher,et al. ANTITHYROID DRUGS IN THE TREATMENT OF HYPERTHYROIDISM OF Graves' DISEASE: LONG‐TERM FOLLOW‐UP OF 434 PATIENTS , 1989, Clinical endocrinology.
[12] R. Holle,et al. Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. , 1989, Acta endocrinologica.